$99

VA LU E
Contents

Introduction 2

CAI International (CAI) 3

Crocs, Inc. (CROX) 4

H&E Equipment Services (HEES) 5

Jazz Pharmaceuticals (JAZZ) 6

MasTec (MTZ) 7

Sanderson Farms (SAFM) 8

Texas Instruments (TXN) 9

What to Do Next 10

7 Best Stocks for the Next 30 Days 1

Introduction

The predictive ability of the Zacks Rank cannot be denied. In fact, since 1988, if you invested
in Zacks Rank #1 stocks, you would have averaged a gain of +25% per year. This perfor-
mance has been examined and attested by Baker Tilly Virchow Krause, LLP,* an indepen-
dent accounting firm.

Now, in this report, youll receive highlights on 7 stocks from the more than 200 companies
that compose the coveted Zacks #1 Rank List. Remember only 5% of all stocks covered by
the proprietary Zacks Rank system have the promise and potential to beat the market in
the next 30 days like these Strong Buy stocks.

Inside this report, youll discover the company financials, earnings data and analysis of
these 7 promising companies.

7 Best Stocks for the Next 30 Days 2

CAI
International
(CAI)

CAI International (CAI) is a Zacks

Rank #1 (Strong Buy) in the trans-
portation equipment and leasing
industry, which ranks in the Top
38% of our Zacks Industry Rank.

The company operates as a trans-

portation finance and logistics
company. Theres been a big
jump in earnings recently, not just
because of high utilization of its
container fleet, but also because of
newly acquired containers that are
fully leased out.

The company has recently purchased over $152 million worth of new containers. In addi-
tion to this huge chunk, they have plans for another $227 million. A growing fleet with
high utilization means their EPS could continue to grow for the next several years. Three
analysts have come out recently and increased their estimates for the current quarter, next
quarter, the current year and next year.

7 Best Stocks for the Next 30 Days 3

Crocs, Inc.
(CROX)

Crocs, Inc. (CROX) makes casual

footwear for men, women and chil-
dren. It is expected to see positive
earnings in 2018 for the first time in
4 years.

The company reported second

quarter results on Aug 10 and beat
the Zacks Consensus for the second
quarter in a row. Earnings were
$0.27 versus the Zacks Consensus of
$0.15.

Revenues fell 2.7% to $313.2 million, but it was at the high end of the companys guid-
ance. Analysts are liking what they are seeing and getting more bullish on the company.
Although sales are expected to drop by about 2.2% this year, they expect a rebound of 3%
in 2018. By 2018, analysts expect the company to be back in the green as far as earnings.
The stock has jumped 39% year-to-date.

7 Best Stocks for the Next 30 Days 4

H&E
Equipment
Services (HEES)

H&E Equipment Services (HEES)

is one of the largest integrated
equipment services companies in
the United States.

It announced the acquisition of

Neff Corporation on July 27 and at
the same time released news of a
solid beat of the Zacks Consensus
Estimate.

The company topped forecasts by 33% but most of the attention was paid to the $1.2B deal.
The Zacks Rank is focused on the movement of earnings estimates. The Zacks Consensus
Estimate only has a number for FY2018, and that estimate has been moving up. Roughly 90
days ago the number stood at $1.12 but following the big earnings beat, the number moved
higher to $1.36.

7 Best Stocks for the Next 30 Days 5

Jazz
Pharmaceuticals
(JAZZ)

Jazz Pharmaceuticals (JAZZ) is a $9

billion drug company focused on
neurology, psychiatry, and oncol-
ogy.

Their top commercially-successful

drug is Xyrem for the treatment
of narcolepsy, which will comprise
nearly 75% of total projected sales
this year.

The second most-important revenue generator is Erwinaze, part of a chemotherapy

program to treat patients who have acute lymphoblastic leukemia. On August 3, the U.S.
Food and Drug Administration (FDA) approved the Jazz Pharmaceuticals drug Vyxeos
for the treatment of adults with two types of acute myeloid leukemia (AML). Bottom
line: Investors and analysts really like this steady pharma profit-machine among biotech
gambles still years away from bringing drugs to market.

7 Best Stocks for the Next 30 Days 6

MasTec (MTZ)

MasTec (MTZ) is a $3.3 billion engi-

neering and construction (E&C)
company specializing in energy
and telecom sector projects.

Another strong quarterly report

and raised guidance in early
August has put the stock in the
upper echelon of the Zacks Rank
once again.

The stock just absorbed a lot of uncertainty surrounding the Gulf hurricanes, where both
energy projects in Houston and telecom projects in Florida could have been impacted more
severely. Now that the damage is being assessed, its seen that rebuilding efforts can now
be a boost for MasTec. As estimates stand right now, MasTec looks poised to grow the top
line by over 16% this year and the bottom one by 45%. Next years revenues are projected
to grow by 6% to $6.34 billion.

7 Best Stocks for the Next 30 Days 7

Sanderson
Farms (SAFM)

Sanderson Farms (SAFM) is a fully-

integrated poultry processing
company.

It recently reported Q3 17 results

that easily beat the Zacks Consensus
Estimates for earnings and revenues
for the second consecutive quarter.

On a year over year basis the

company saw net sales up +28%,
and net income rose by +111.7%.

Management also stated that they are starting construction this month on new Tyler Texas
facilities, and that their new facility in St Pauls North Carolina is now operating at three quarters
capacity and remains on track to reach full capacity in January of 2018. Over the past 30 days
earnings estimates for Q4 17, Q1 18, FY 17 and FY 18 have all seen significant upgrades.

7 Best Stocks for the Next 30 Days 8

Texas
Instruments
(TXN)

Texas Instruments (TXN) is a global

semiconductor company that
reported excellent results for the
second quarter, exceeding Zacks
Consensus Estimates for both earn-
ings and revenues.

Strong results were driven by

growth in the auto, industrial,
communications and personal elec-
tronics markets.

The company also upgraded its guidance for the third quarter. Analysts have been raising their
estimates for the company after stronger than expected results and updated guidance. In
addition to a top Zacks Rank, the stock has Zacks Style Scores of A for Momentum while the
Semiconductor--General Industry is currently ranked 3rd out of 265 Zacks Industries (top 1%).

7 Best Stocks for the Next 30 Days 9

What to Do Next

In addition to the hand-selected picks included in this special

report, you can move yourself way ahead of the crowd in any
market environment with the following:
As part of this free report, you will now receive our free daily e-newsletter, Profit from
the Pros. Each morning, Executive Vice President Steve Reitmeister will summarize
the market, what it means for investors and what to do next. Plus you get links to
articles featuring some of our top stock, ETF and mutual fund recommendations.
Be sure to look for it in your email inbox before the markets open every day.

Now you should bookmark our homepage to take advantage of one of the most
complete investment websites around. Go there now:

www.zacks.com

Even better, get all Zacks private buys and sells through our Zacks Ultimate program.
Watch our trades and market insights from all of Zacks private portfolios from growth
to value to momentum stocks, from insider moves to big earnings surprises, from
options to ETFs, even trades EVP Steve Reitmeister makes in his personal account, and
much more. This see-everything arrangement is unique: one month, one dollar, not
one cent of further obligation.

Learn more about the Zacks Ultimate Trial now.

7 Best Stocks for the Next 30 Days 10

Copyright 2017 Zacks Investment Research

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making
your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks Terms and
Conditions of Service disclaimer. www.zacks.com/disclaimer.

*Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material
is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting
or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as
to whether any investment is suitable for a particular investor. It should not be assumed that any investments in
securities, companies, sectors or markets identified and described were or will be profitable. All information is current
as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect
those of the firm as a whole. Zacks Investment Research is not a licensed securities dealer, broker or US investment
adviser or investment bank. The Zacks #1 Rank Performance covers a period beginning on January 1, 1988 through
December 31, 2016 and was examined and attested by Baker Tilly Virchow Krause, LLP, an independent accounting
firm. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank # 1 that were rebalanced
monthly (see additional details regarding rebalancing below) with zero transaction costs. These are not the returns of
actual portfolios of stocks. Zacks Rank #1 stock-rating system returns are computed monthly based on the beginning
of the month and end of the month Zacks Rank #1 stock prices plus any dividends received during that particular
month. A simple, equally-weighted average return of all Zacks Rank #1 stocks is calculated to determine the monthly
return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank #1 stocks included
in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zack Rank #1
stocks can, and often do, change throughout the month. Certain Zacks Rank #1 stocks for which no month-end price
was available, pricing information was not collected, or for certain other reasons have been excluded from these
return calculations. The S&P 500 is an unmanaged index. Visit www.zacks.com/performance for information about
the performance numbers displayed above.

7 Best Stocks for the Next 30 Days 11